URECHOLINE(BETHANECHOL CHLORIDE) - 美国FDA药品数据库

药品名称	URECHOLINE
申请号	006536	产品号	001
活性成分	BETHANECHOL CHLORIDE	市场状态	停止上市
剂型或给药途径	INJECTABLE;INJECTION	规格	5MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons
治疗等效代码		参比药物	否
批准日期	Approved Prior to Jan 1, 1982	申请机构	ODYSSEY PHARMACEUTICALS INC
化学类型		审评分类

与本品相关的专利信息（来自橙皮书Orange Book）
专利号	专利过期日	是否化合物专利	是否产品专利	专利用途代码	专利下载
无
历史专利信息
无

药品注册审批历史信息
申请号	修订号	审批结论	审批日期	审批内容
006536	043	AP	1998/01/20	Control Supplement
006536	042	AP	1998/03/31	Control Supplement
006536	041	AP	1997/08/14	Control Supplement
006536	040	AP	1996/09/03	Manufacturing Change or Addition
006536	039	AP	1996/03/11	Control Supplement
006536	038	AP	1998/04/02	Labeling Revision
006536	037	AP	1995/09/11	Manufacturing Change or Addition
006536	036	AP	1993/08/09	Labeling Revision
006536	035	AP	1992/08/28	Control Supplement
006536	034	AP	1987/03/09	Labeling Revision
006536	033	AP	1985/09/12	Control Supplement
006536	032	AP	1985/07/03	Package Change
006536	031	AP	1984/10/11	Package Change
006536	030	AP	1984/10/24	Control Supplement
006536	029	AP	1983/09/16	Formulation Revision
006536	028	AP	1986/01/14	Practioner Draft Labeling
006536	027	AP	1981/07/14	Package Change
006536	026	AP	1981/11/03	Manufacturing Change or Addition
006536	025	AP	1981/06/17	Package Change
006536	024	AP	1980/12/22	Formulation Revision
006536	023	AP	1980/05/01	Labeling Revision
006536	022	AP	1980/05/29	Control Supplement
006536	021	AP	1980/06/24	Labeling Revision
006536	020	AP	1979/08/13	Labeling Revision
006536	018	AP	1980/05/01	Labeling Revision
006536	017	AP	1980/05/01	Labeling Revision
006536	016	AP	1978/10/02	Labeling Revision
006536	015	AP	1977/12/12	Control Supplement
006536	014	AP	1977/09/19	Labeling Revision
006536	013	AP	1976/05/17	Labeling Revision
006536	012	AP	1976/05/17	Control Supplement
006536	000	AP	1948/10/12	Approval